

					

						November 22, 2017 - By Winifred Garcia
Allan Teh decreased its stake in Platform Specialty Prods Cor (PAH) by 49.71% based on its latest 2017Q2 regulatory filing with the SEC. Kamunting Street Capital Management Lp sold 67,802 shares as the company’s stock rose 0.60% with the market. The hedge fund run by Allan Teh held 68,582 shares of the major chemicals company at the end of 2017Q2, valued at $870,000, down from 136,384 at the end of the previous reported quarter. Kamunting Street Capital Management Lp who had been investing in Platform Specialty Prods Cor for a number of months, seems to be less bullish one the $2.86B market cap company. The stock declined 1.05% or $0.11 reaching $9.86 per share. About 152,876 shares traded. Platform Specialty Products Corp (NYSE:PAH) has risen 48.23% since November 22, 2016 and is uptrending. It has outperformed by 31.53% the S&P500.Nelson Roberts Investment Advisors Llc increased its stake in Bristol Myers Squibb (BMY) by 3514.17% based on its latest 2017Q2 regulatory filing with the SEC. Nelson Roberts Investment Advisors Llc bought 84,340 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 86,740 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $4.83M, up from 2,400 at the end of the previous reported quarter. Nelson Roberts Investment Advisors Llc who had been investing in Bristol Myers Squibb for a number of months, seems to be bullish on the $100.51B market cap company. The stock rose 0.28% or $0.17 reaching $61.41 per share. About 371,637 shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since November 22, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.Investors sentiment is 1.67 in 2017 Q2. Its the same as in 2017Q1. It is flat, as 22 investors sold PAH shares while 45 reduced holdings. only 33 funds opened positions while 79 raised stakes. 240.34 million shares or 2.20% more from 235.17 million shares in 2017Q1 were reported. Tiaa Cref Investment Lc has invested 0.01% in Platform Specialty Products Corp (NYSE:PAH). Bluemountain Mgmt Llc holds 195,725 shares. Guggenheim Ltd owns 58,394 shares. Great West Life Assurance Can owns 23,429 shares for 0% of their portfolio. Tributary Management Ltd Liability Corp invested 0.16% of its portfolio in Platform Specialty Products Corp (NYSE:PAH). Canada Pension Plan Investment Board owns 104,410 shares. Fincl Bank Of Montreal Can holds 0.01% of its portfolio in Platform Specialty Products Corp (NYSE:PAH) for 1.04 million shares. Columbus Circle reported 0.18% of its portfolio in Platform Specialty Products Corp (NYSE:PAH). Brigade Limited Partnership invested in 1.1% or 1.05 million shares. Hanseatic Mgmt Svcs stated it has 0.01% of its portfolio in Platform Specialty Products Corp (NYSE:PAH). Tokio Marine Asset holds 0.26% or 142,500 shares. 66,765 are held by Credit Suisse Ag. California Public Employees Retirement Systems invested in 438,900 shares. Zacks Invest Mgmt has 0.01% invested in Platform Specialty Products Corp (NYSE:PAH). Private Grp Inc Inc accumulated 1.76 million shares.More notable recent Platform Specialty Products Corp (NYSE:PAH) news were published by: Nasdaq.com which released: “Platform Specialty Products Enters Oversold Territory (PAH)” on November 02, 2017, also Globenewswire.com with their article: “Platform Specialty Products Corporation Announces Date for Release of 2017 …” published on October 23, 2017, Globenewswire.com published: “Platform Specialty Products Corporation Announces Pricing of Senior Notes Offering” on November 09, 2017. More interesting news about Platform Specialty Products Corp (NYSE:PAH) were released by: Globenewswire.com and their article: “Platform Specialty Products Corporation Announces Third Quarter of 2017 …” published on November 02, 2017 as well as Seekingalpha.com‘s news article titled: “Platform Specialty Products’ (PAH) CEO Rakesh Sachdev on Q3 2017 Results …” with publication date: November 05, 2017.Among 10 analysts covering Platform Specialty Products Corporation (NYSE:PAH), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Platform Specialty Products Corporation had 25 analyst reports since August 17, 2015 according to SRatingsIntel. The stock of Platform Specialty Products Corp (NYSE:PAH) has “Buy” rating given on Wednesday, March 9 by Bank of America. The stock of Platform Specialty Products Corp (NYSE:PAH) has “Buy” rating given on Thursday, November 2 by Roth Capital. On Thursday, December 3 the stock rating was reinitiated by Credit Suisse with “Neutral”. The rating was maintained by Barclays Capital on Wednesday, October 5 with “Equal Weight”. The company was maintained on Thursday, September 29 by UBS. The rating was reinitiated by Credit Suisse with “Neutral” on Monday, May 2. Credit Suisse maintained Platform Specialty Products Corp (NYSE:PAH) rating on Wednesday, November 15. Credit Suisse has “Neutral” rating and $12 target. The stock of Platform Specialty Products Corp (NYSE:PAH) earned “Buy” rating by Goldman Sachs on Monday, February 6. The stock has “Equal-Weight” rating by Barclays Capital on Wednesday, October 11. Nomura maintained the stock with “Buy” rating in Tuesday, June 13 report.Analysts await Platform Specialty Products Corp (NYSE:PAH) to report earnings on February, 27. They expect $0.24 EPS, up 20.00% or $0.04 from last year’s $0.2 per share. PAH’s profit will be $69.61 million for 10.27 P/E if the $0.24 EPS becomes a reality. After $0.17 actual EPS reported by Platform Specialty Products Corp for the previous quarter, Wall Street now forecasts 41.18% EPS growth. Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Sell” rating on Wednesday, August 16 by BMO Capital Markets. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Sell” rating given on Wednesday, April 6 by Societe Generale. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Hold” rating by Piper Jaffray on Thursday, October 26. BMO Capital Markets maintained the stock with “Sell” rating in Sunday, July 23 report. The rating was maintained by Jefferies with “Hold” on Tuesday, June 14. Cowen & Co maintained the stock with “Hold” rating in Monday, September 18 report. The stock has “Underweight” rating by Piper Jaffray on Monday, August 24. The firm has “Hold” rating by Credit Suisse given on Wednesday, August 16. The firm earned “Hold” rating on Thursday, July 14 by Jefferies. Berenberg downgraded Bristol-Myers Squibb Co (NYSE:BMY) on Thursday, August 11 to “Hold” rating.Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.03, from 0.98 in 2017Q1. It turned negative, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported. Royal State Bank Of Canada has invested 0.13% in Bristol-Myers Squibb Co (NYSE:BMY). Halsey Ct holds 0.06% or 5,670 shares in its portfolio. Oregon Pub Employees Retirement Fund has invested 0.36% in Bristol-Myers Squibb Co (NYSE:BMY). Manning Napier Advsr Lc, a New York-based fund reported 2.03 million shares. Texan holds 0.18% or 4,900 shares in its portfolio. The Texas-based Ray Gerald L Ltd has invested 1.23% in Bristol-Myers Squibb Co (NYSE:BMY). Financial Advisers Ltd Liability Co has invested 0.14% in Bristol-Myers Squibb Co (NYSE:BMY). Pathstone Family Office Ltd Llc stated it has 0.54% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Timber Creek Cap Mgmt Limited Liability Corp has 0.07% invested in Bristol-Myers Squibb Co (NYSE:BMY). Neville Rodie & Shaw, a New York-based fund reported 95,938 shares. Thompson Siegel & Walmsley Lc holds 15,223 shares or 0.01% of its portfolio. Trustco Bancorp N Y invested 1.25% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Athena Cap Advsr Ltd accumulated 1.19% or 82,800 shares. Optimum Inv invested in 57,119 shares or 1.1% of the stock. Tiaa Cref Invest Mgmt Ltd Liability holds 6.96M shares or 0.27% of its portfolio.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading